Docetaxel (DT) in anthracycline-pretreated advanced breast cancer (ABC): Toxicity and activity

被引：0
|
作者：
Ferraresi, V [1 ]
Vaccaro, A [1 ]
Milella, M [1 ]
D'Ottavio, AM [1 ]
Papaldo, P [1 ]
Nistico, C [1 ]
Thorel, MF [1 ]
Marsella, A [1 ]
Terzoli, E [1 ]
Cognetti, F [1 ]
机构：
[1] Regina Elena Canc Inst, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
88P
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [41] Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance
    Moon, Yong Wha
    Sohn, Joo Hyuk
    Choi, Hye Jin
    Chang, Hyun
    Park, Byeong-Woo
    Kim, Seung Il
    Park, Seho
    Koo, Ja Seung
    Kim, Yong Tai
    Roh, Jae Kyung
    Chung, Hyun Cheol
    Kim, Joo-Hang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 425 - 431
  • [42] A phase I dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer
    Slee, PHTJ
    Rodenburg, CJ
    Nortier, JWR
    van Bochove, A
    NETHERLANDS JOURNAL OF MEDICINE, 2004, 62 (09): : 314 - 319
  • [43] Docetaxel in patients with anthracycline-resistant advanced breast cancer
    Vici, P
    Belli, F
    Di Lauro, L
    Amodio, A
    Conti, F
    Foggi, P
    Gionfra, T
    Morelli, MF
    Botti, C
    Ferraironi, A
    Lopez, M
    ONCOLOGY, 2001, 60 (01) : 60 - 65
  • [44] A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer
    Bayo, Juan
    Lomas, Maria
    Salvador, Javier
    Moreno, Alberto
    Ruiz, Manuel
    Rodriguez, Alberto
    Fuentes, Jose
    Fernandez-Freire, Ana
    Bernabe, Reyes
    Fernandez, Andrea
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (12): : 817 - 825
  • [45] Docetaxel in paclitaxel-pretreated advanced breast cancer patients
    Nisticò, C
    Vaccaro, A
    Milella, M
    D'Ottavio, AM
    Garufi, C
    Rosati, N
    Papaldo, P
    Tropea, F
    Zappalà, A
    Terzoli, E
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S326 - S327
  • [46] Gemcitabine plus docetaxel (GD) versus capecitabine plus docetaxel (CD) for anthracycline-pretreated metastatic breast cancer (MBC) patients (pts): Results of a European phase III study.
    Chan, S
    Romieu, G
    Huober, J
    Delozier, T
    Tubiana-Hulin, M
    Lluch, A
    Schneeweiss, A
    Llombart, A
    Carrasco, E
    Fumoleau, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 24S - 24S
  • [47] Gemcitabine (GEM) plus oxaliplatin (LOHP) as salvage treatment in anthracycline and taxane pretreated patients with advanced breast cancer (ABC)
    Kalikaki, A.
    Potamianou, A.
    Malamos, N.
    Syrigos, K.
    Kalbakis, K.
    Androulakis, N.
    Vamvakas, L.
    Bozionelou, V.
    Kotsakis, A.
    Mavroudis, D.
    EJC SUPPLEMENTS, 2005, 3 (02): : 129 - 130
  • [48] A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer
    Juan Bayo
    María Lomas
    Javier Salvador
    Alberto Moreno
    Manuel Ruiz
    Alberto Rodríguez
    José Fuentes
    Ana Fernández-Freire
    Reyes Bernabé
    Andrea Fernández
    Clinical and Translational Oncology, 2008, 10
  • [49] A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer
    Hugo E. R. Ford
    Yoon-Sim Yap
    David W. Miles
    Andreas Makris
    Marcia Hall
    Liz Miller
    Mark Harries
    Ian E. Smith
    Stephen R. D. Johnston
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 809 - 815
  • [50] Combination chemotherapy with docetaxel and gemcitabine in anthracycline pretreated patients with metastatic breast cancer (MBC).
    Slee, PHTHJ
    Jong, PC
    Jong, RS
    Honkoop, AH
    Coenen, JLLM
    Rodenburg, CJ
    Rooda, SJE
    Douma, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 60S - 60S
12345